WVE - Wave Life Sciences Ltd logo

Wave Life Sciences Ltd

WVE

Wave Life Sciences Ltd develops RNA medicines using its PRISM platform, focusing on treatments for rare and common disorders. Key products include therapies for alpha-1 antitrypsin deficiency, obesity, liver disease, Duchenne muscular dystrophy, and Huntington's disease.

⚕️ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago →$112today

Score Overview

1 Year
Score
Net Growth0.93%
Net TrendGrew
Net Income Consistency—
Rev Growth53.00%
Rev TrendGrew
Revenue Consistency—
5 Years
Score3.6
Net Growth-65.63%
Net Trend40%
Net Income Consistency—
Rev Growth59.58%
Rev Trend40%
Revenue Consistency—
10 Years
Score
Net Growth-265.47%
Net Trend40%
Net Income Consistency
Rev Growth44x
Rev Trend70%
Revenue Consistency
All Time
Score
Net Growth-8x
Net Trend36%
Net Income Consistency
Rev Growth430x
Rev Trend73%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Wave Life Sciences Ltd has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. WVE does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-21
$ 3.37—
1 Year2025-10-21
$ 7.85-57.07%
5 Years2021-10-21
$ 4.39-23.23%
10 Years2016-10-21
$ 30.14-88.82%
All Time2015-11-11
$ 16.00-78.94%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 65M-$ 202M$ 490M
2025$ 42M-$ 204M$ 602M
2024$ 108M-$ 97M$ 302M
2023$ 113M-$ 57M$ 200M
2022$ 3M-$ 161M$ 88M
2021$ 40M-$ 122M$ 150M
2020$ 20M-$ 149M$ 184M
2019$ 15M-$ 193M$ 147M
2018$ 14M-$ 146M$ 174M
2017$ 3M-$ 102M$ 142M
2016$ 1M-$ 55M$ 150M
IPO2015$ 152K-$ 19M$ 161M
WVE - Wave Life Sciences Ltd logo

Wave Life Sciences Ltd fundamental performance

Between 2020 and 2025, revenue grew from $ 20M to $ 42M and net income went from -$ 149M to -$ 204M. Revenue increased in 2 of those 5 years; net income in 2.

Across Wave Life Sciences Ltd's full reported history, from 2015 to 2025, revenue grew from $ 152K to $ 42M and net income went from -$ 19M to -$ 204M. Revenue increased in 73% of the years measured; net income in 36%.

Wave Life Sciences Ltd currently holds a 5-year HDB Score of 3.6 out of 10. How the HDB Score is calculated.

Membership

Explore WVE with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,118 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies